Brainstorm Cell Therapeutics CEO Anthony S. Fiorino purchased 1,200 shares of Brainstorm Cell Therapeutics stock in a transaction dated Monday, September 15th. The stock was purchased at an average price of $0.28 per share, with a total value of $336.00.
http://ift.tt/1mkyWdj
http://ift.tt/1mkyWdj
No comments:
Post a Comment